Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Next Previous
X
Search
Trial Profile

Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors, Ketones, and Cardiovascular Benefit Research Plan

Status: Recruiting
Phase of Trial: Phase 0

Latest Information Update: 09 Jan 2024

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Empagliflozin (Primary)
  • Indications Heart failure; Type 2 diabetes mellitus
  • Focus Pharmacodynamics

    • Most Recent Events

    • 26 Jun 2023 Results (n=6) assessing effects of SGLT2i on cardiopulmonary function measured by cardiopulmonary exercise test & 6MWT in patients with T2D & HFrEF presented at the 83rd Annual Scientific Sessions of the American Diabetes Association
    • 14 Feb 2023 Planned End Date changed from 1 Feb 2025 to 31 Mar 2027.
    • 14 Feb 2023 Planned primary completion date changed from 1 Oct 2024 to 30 Nov 2026.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top